FUCHS SE NA ST O.N./ DE000A3E5D56 /
11/11/2024 10:58:09 PM | Chg. +0.550 | Volume | Bid10:58:09 PM | Ask10:58:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
34.700EUR | +1.61% | - Turnover: - |
34.700Bid Size: - | 34.900Ask Size: - | 5.33 bill.EUR | 3.16% | 16.75 |
GlobeNewswire
8/5
Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones...
GlobeNewswire
7/24
The ADVERTISING Club of New York Taps Power Players to Join the Board of Directors; Naming Five New ...
GlobeNewswire
7/24
OTC Markets Group Announces Real-Time Data Distribution with uSMART Securities Out of Hong Kong
GlobeNewswire
7/4
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene The...
GlobeNewswire
5/9
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea E...
GlobeNewswire
5/8
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program M...
GlobeNewswire
5/7
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
5/2
insightsoftware Recognized as DACH Region Market Leader for Sixth Consecutive Year in BARC Score Fin...
GlobeNewswire
4/10
BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Rese...
GlobeNewswire
3/19
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full...
GlobeNewswire
3/12
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive...
GlobeNewswire
3/7
American Institutes for Research Education Experts to Present at the Council for Exceptional Childre...
GlobeNewswire
1/30
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...
GlobeNewswire
1/24
Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host...
GlobeNewswire
12/9/2023
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
11/13/2023
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portf...